CN111748649A - 一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒 - Google Patents
一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒 Download PDFInfo
- Publication number
- CN111748649A CN111748649A CN202010552644.7A CN202010552644A CN111748649A CN 111748649 A CN111748649 A CN 111748649A CN 202010552644 A CN202010552644 A CN 202010552644A CN 111748649 A CN111748649 A CN 111748649A
- Authority
- CN
- China
- Prior art keywords
- virus
- influenza
- sequence
- quality control
- primer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 33
- 241000711573 Coronaviridae Species 0.000 title claims abstract description 29
- 206010022000 influenza Diseases 0.000 title claims abstract description 20
- 241000712461 unidentified influenza virus Species 0.000 title description 10
- 239000000523 sample Substances 0.000 claims abstract description 60
- 238000003908 quality control method Methods 0.000 claims abstract description 35
- 241000712431 Influenza A virus Species 0.000 claims abstract description 18
- 241000713196 Influenza B virus Species 0.000 claims abstract description 16
- 238000003753 real-time PCR Methods 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 8
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 6
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 5
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 5
- 239000008367 deionised water Substances 0.000 claims abstract description 3
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 230000003321 amplification Effects 0.000 claims description 21
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 21
- 244000309467 Human Coronavirus Species 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000011529 RT qPCR Methods 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 101150013191 E gene Proteins 0.000 claims description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 2
- 108700002099 Coronavirus Nucleocapsid Proteins Proteins 0.000 claims description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 2
- 101900234398 Influenza B virus Hemagglutinin Proteins 0.000 claims description 2
- 102100034343 Integrase Human genes 0.000 claims description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 2
- 239000012295 chemical reaction liquid Substances 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 238000010791 quenching Methods 0.000 claims description 2
- 230000000171 quenching effect Effects 0.000 claims description 2
- 238000012207 quantitative assay Methods 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 4
- 238000002372 labelling Methods 0.000 claims 2
- 206010035664 Pneumonia Diseases 0.000 abstract description 12
- 241000700605 Viruses Species 0.000 abstract description 9
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 238000003759 clinical diagnosis Methods 0.000 abstract description 3
- 238000002955 isolation Methods 0.000 abstract description 3
- 238000012544 monitoring process Methods 0.000 abstract description 3
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 description 7
- 238000003745 diagnosis Methods 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 241001678559 COVID-19 virus Species 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000011841 epidemiological investigation Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
荧光通道 | FAM | ROX | Cy5 | VIC |
人甲型流感 | 阳性(+) | 阴性(-) | 阴性(-) | 阴性(-) |
人乙型流感 | 阴性(-) | 阳性(+) | 阴性(-) | 阴性(-) |
新冠肺炎 | 阴性(-) | 阴性(-) | 阳性(+) | 阴性(-) |
新冠肺炎 | 阴性(-) | 阴性(-) | 阴性(-) | 阳性(+) |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010552644.7A CN111748649A (zh) | 2020-06-13 | 2020-06-13 | 一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010552644.7A CN111748649A (zh) | 2020-06-13 | 2020-06-13 | 一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111748649A true CN111748649A (zh) | 2020-10-09 |
Family
ID=72675437
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010552644.7A Pending CN111748649A (zh) | 2020-06-13 | 2020-06-13 | 一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111748649A (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112410467A (zh) * | 2020-11-23 | 2021-02-26 | 深圳市赛格诺生物科技有限公司 | 一种检测甲型和乙型流感病毒的冻干型荧光rt-pcr试剂及方法 |
CN112410470A (zh) * | 2020-12-03 | 2021-02-26 | 江苏默乐生物科技股份有限公司 | 新型冠状病毒和甲型、乙型流感病毒核酸快速检测试剂盒 |
CN112501356A (zh) * | 2020-12-16 | 2021-03-16 | 山东省动物疫病预防与控制中心 | 一种水貂冠状病毒与新型冠状病毒快速鉴别检测的探针引物组、试剂盒及其检测方法 |
CN112662540A (zh) * | 2020-12-24 | 2021-04-16 | 王安刚 | 一种医学检验新冠病毒标本检测装置 |
CN112795695A (zh) * | 2020-12-31 | 2021-05-14 | 湖南中医药大学 | 用于检测新冠病毒的荧光pcr检测试剂盒及检测方法 |
CN112831605A (zh) * | 2021-02-19 | 2021-05-25 | 杭州宝临生物科技有限公司 | 多酶恒温扩增检测试剂盒及其应用 |
US11214843B2 (en) | 2020-02-18 | 2022-01-04 | Life Technologies Corporation | Compositions, kits and methods for detection of viral sequences |
CN117126965A (zh) * | 2023-08-18 | 2023-11-28 | 苏州创澜生物科技有限公司 | 一种引物探针组合物、试剂盒及应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090181360A1 (en) * | 2007-12-21 | 2009-07-16 | Jules Chen | Multiplex detection assay for influenza and rsv viruses |
CN103614495A (zh) * | 2013-12-02 | 2014-03-05 | 上海之江生物科技股份有限公司 | 甲型和乙型流感病毒联合检测试剂盒及其应用 |
CN111088408A (zh) * | 2020-03-20 | 2020-05-01 | 广州凯普医药科技有限公司 | 一种新冠病毒、甲乙流感及呼吸道合胞病毒检测试剂盒 |
CN111100954A (zh) * | 2020-02-08 | 2020-05-05 | 中华人民共和国无锡海关 | 同时检测包括2019-nCoV在内的四种人冠状病毒的四重荧光定量检测试剂盒 |
CN111254228A (zh) * | 2020-05-06 | 2020-06-09 | 上海思路迪医学检验所有限公司 | 一种检测新型冠状病毒和流感病毒的试剂盒 |
-
2020
- 2020-06-13 CN CN202010552644.7A patent/CN111748649A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090181360A1 (en) * | 2007-12-21 | 2009-07-16 | Jules Chen | Multiplex detection assay for influenza and rsv viruses |
CN103614495A (zh) * | 2013-12-02 | 2014-03-05 | 上海之江生物科技股份有限公司 | 甲型和乙型流感病毒联合检测试剂盒及其应用 |
CN111100954A (zh) * | 2020-02-08 | 2020-05-05 | 中华人民共和国无锡海关 | 同时检测包括2019-nCoV在内的四种人冠状病毒的四重荧光定量检测试剂盒 |
CN111088408A (zh) * | 2020-03-20 | 2020-05-01 | 广州凯普医药科技有限公司 | 一种新冠病毒、甲乙流感及呼吸道合胞病毒检测试剂盒 |
CN111254228A (zh) * | 2020-05-06 | 2020-06-09 | 上海思路迪医学检验所有限公司 | 一种检测新型冠状病毒和流感病毒的试剂盒 |
Non-Patent Citations (2)
Title |
---|
L J VAN ELDEN等: "Simultaneous detection of influenza viruses A and B using real-time quantitative PCR", 《J CLIN MICROBIOL》 * |
连昌虎等: "六重荧光RT-PCR快速检测A、B型流感等呼吸道病毒方法的建立", 《热带医学杂志》 * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11214843B2 (en) | 2020-02-18 | 2022-01-04 | Life Technologies Corporation | Compositions, kits and methods for detection of viral sequences |
CN112410467A (zh) * | 2020-11-23 | 2021-02-26 | 深圳市赛格诺生物科技有限公司 | 一种检测甲型和乙型流感病毒的冻干型荧光rt-pcr试剂及方法 |
CN112410470A (zh) * | 2020-12-03 | 2021-02-26 | 江苏默乐生物科技股份有限公司 | 新型冠状病毒和甲型、乙型流感病毒核酸快速检测试剂盒 |
CN112410470B (zh) * | 2020-12-03 | 2023-11-07 | 江苏默乐生物科技股份有限公司 | 新型冠状病毒和甲型、乙型流感病毒核酸快速检测试剂盒 |
CN112501356A (zh) * | 2020-12-16 | 2021-03-16 | 山东省动物疫病预防与控制中心 | 一种水貂冠状病毒与新型冠状病毒快速鉴别检测的探针引物组、试剂盒及其检测方法 |
NL2030146A (en) * | 2020-12-16 | 2022-06-02 | Shandong Provincial Center For Animal Disease Control And Prevention | Probe and primer set for rapid identification and detection of mink coronavirus (mcov) and 2019 novel coronavirus (2019-ncov), and kit and detection method thereof |
CN112662540A (zh) * | 2020-12-24 | 2021-04-16 | 王安刚 | 一种医学检验新冠病毒标本检测装置 |
CN112795695A (zh) * | 2020-12-31 | 2021-05-14 | 湖南中医药大学 | 用于检测新冠病毒的荧光pcr检测试剂盒及检测方法 |
CN112831605A (zh) * | 2021-02-19 | 2021-05-25 | 杭州宝临生物科技有限公司 | 多酶恒温扩增检测试剂盒及其应用 |
CN117126965A (zh) * | 2023-08-18 | 2023-11-28 | 苏州创澜生物科技有限公司 | 一种引物探针组合物、试剂盒及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111748649A (zh) | 一种同时检测人流感病毒与新型冠状病毒的荧光定量检测试剂盒 | |
US20080003565A1 (en) | Viral nucleic acid microarray and method of use | |
CN106906306B (zh) | 快速并灵敏基因型鉴定及核酸检测 | |
JP2014511177A (ja) | 呼吸器系ウイルスによる疾患の同時診断キット | |
CN111808989A (zh) | 一种冠状病毒/流感病毒/鼻病毒核酸联合检测试剂盒及使用方法 | |
WO2022089550A1 (en) | Novel compositions and methods for coronavirus detection | |
CN110358815B (zh) | 一种同时检测多个靶标核酸的方法及其试剂盒 | |
CN104846125A (zh) | 一种用于检测mers的荧光rt-pcr引物、探针和试剂盒及检测方法 | |
CN110317861B (zh) | 一种检测病原体的试剂盒 | |
CN116171333A (zh) | 用于检测严重急性呼吸综合征冠状病毒2(sars-cov-2)、甲型流感和乙型流感的组合物和方法 | |
CN113005228B (zh) | 一种同步检测多项呼吸道病原体的检测试剂盒及其检测方法 | |
JP2022547023A (ja) | 感染の宿主rnaバイオマーカーの迅速な早期検出及びヒトにおけるcovid-19コロナウイルス感染の早期同定のためのシステム、方法、及び組成物。 | |
CN113652505A (zh) | 检测新型冠状病毒及其voc-202012/01突变株的方法和试剂盒 | |
US20220042117A1 (en) | COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) | |
CN114032337A (zh) | 一种呼吸道病原体检测试剂盒及其制备方法与应用 | |
WO2023116064A1 (en) | Composition, kit and method for detection of sars-cov-2 and use thereof | |
KR102435209B1 (ko) | 인플루엔자 a형 및 b형 바이러스와 제2형 중증급성호흡기증후군 코로나바이러스를 구별하여 동시에 검출하기 위한 조성물 및 이를 이용한 검출 방법 | |
CN111910023B (zh) | 用于检测新型冠状病毒的引物探针组合、试剂盒和方法 | |
KR20220040834A (ko) | 분자 비콘 프로브를 포함하는 covid-19 진단 멀티플렉스 lamp 조성물 | |
CN113215329A (zh) | 呼吸道7种亚型流感病毒多重pcr检测的引物、探针和试剂盒 | |
KR101809710B1 (ko) | 조류 인플루엔자 바이러스 뉴라미다아제 아형 검출용 프라이머 및 이의 용도 | |
RU2734636C1 (ru) | Способ индикации и идентификации штаммов возбудителя чумы по их принадлежности к виду yersinia pestis, к подвидам, биоварам, филогенетическим ветвям и по наличию генов основных факторов патогенности методом днк-чипа | |
KR102402765B1 (ko) | SARS-CoV-2 감염 진단을 위한 멀티플렉스 RT-LAMP용 조성물 및 이의 용도 | |
KR102572368B1 (ko) | 파라인플루엔자 바이러스 1형 및 3형 동시 감별 검출용 프라이머 세트 및 이의 용도 | |
US20230043710A1 (en) | Methods and kits for the detection of sars-cov-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
CB02 | Change of applicant information |
Address after: Room 302, building 8-3, 160 basheng Road, No.1 Free Trade Zone, Waigaoqiao, Pudong, Shanghai 200131 Applicant after: SHANGHAI HOMOGENE TECHNOLOGY Co.,Ltd. Address before: 200433 room 206, 275-8 Guoding East Road, Yangpu District, Shanghai Applicant before: SHANGHAI HOMOGENE TECHNOLOGY Co.,Ltd. |
|
CB02 | Change of applicant information | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 200131 Room 302, building 8-3, 160 basheng Road, Waigaoqiao Free Trade No.1, Pudong New Area, Shanghai Applicant after: SHANGHAI HOMOGENE TECHNOLOGY Co.,Ltd. Address before: Room 302, building 8-3, 160 basheng Road, No.1 Free Trade Zone, Waigaoqiao, Pudong, Shanghai 200131 Applicant before: SHANGHAI HOMOGENE TECHNOLOGY Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Wu Lan Document name: Notification of eligibility |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Wu Lan Document name: Deemed withdrawal notice |
|
DD01 | Delivery of document by public notice | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20201009 |
|
WD01 | Invention patent application deemed withdrawn after publication |